Advanced Search

 

Study ID Status Title Patient Level Data
29060/176 Completed An investigation of the single-dose pharmacokinetics of BRL 29060 (30 mg pfb) in elderly healthy volunteers
29060/177 Completed A single-blind study to determine pharmacokinetics and tolerance of paroxetine and methyldopa and any interaction between them under steady state conditions of both compounds
29060/178 Completed A single dose pharmacokinetic study with paroxetine in subjects with hepatic impairment
29060/179 Completed Pharmacokinetics of paroxetine before and after multiple oral dosing of phenytoin to healthy male volunteers
29060/180 Completed An open two-part crossover study to investigate bioavailability of BRL 29060 (Paroxetine) in healthy male volunteers after a single oral dose of 30 mg with and without the concurrent administration of milk.
29060/181 Completed An open two-part crossover study to investigate the bioavailability of BRL 29060 (Paroxetine) in healthy male volunteers after a single oral dose of 60 mg BRL 29060 with and without activated charcoal.
29060/182 Completed A double-blind, placebo controlled two-part crossover study to investigate bioavailability of BRL 29060 (paroxetine) in healthy male volunteers after a single oral dose of 60 mg BRL 29060 in the fasting and non-fasting states.
29060/183 Completed Open single dose pharmacokinetic study with paroxetine in elderly volunteers
29060/187 Completed A Double-Blind Placebo Controlled Comparative Study of Paroxetine and Clomipramine in the Treatment of Panic Disorder. Study Listed on ClinicalStudyDataRequest.com
29060/189 Completed A Double-Blind Randomized Study to Provide Safety Information on Switching Fluoxetine-Treated Patients to Paroxetine without an Intervening Washout Period
29060/190 Completed A Double-Blind, Comparative, Placebo-Controlled Trial of Paroxetine in the Prevention of Recurrent Depression
29060/197 Completed A Double-Blind Comparison of the Efficacy and Tolerability of Paroxetine and Imipiramine in the Treatment of Depression and Behavioural Disturbance Associated with Dementia
29060/201 Completed A Double-Blind, Placebo Controlled Study, to Assess the Efficacy of Paroxetine in the Prevention of Relapse Following Detoxification in Alcoholics
29060/222 Completed A Double-Blind, Placebo-Controlled, Continuation of Study 29060/120 to Assess the Long Term Safety and Efficacy of Paroxetine in the Treatment of Panic Disorder and its Role in the Prevention of Relapse/Recurrence
29060/223 Completed A Double-Blind, Multicentered, Flexible-Dose Study of Paroxetine, Alprazolam and Placebo in the Treatment of Panic Disorder Study Listed on ClinicalStudyDataRequest.com
29060/228 Completed A Long-Term Extension of a Double-Blind, Placebo -Controlled Comparative Study of Paroxetine and Clomipramine in the Treatment of Panic Disorder
29060/238 Completed A study to determine the steady-state pharmacokinetics of paroxetine (20 mg o.d. p.o. for 18 days) in subjects with impaired renal function.
29060/239 Completed A Randomized, Comparative Study of Paroxetine in the Treatment of Depression as Used in a Clinical Practice Setting
29060/239_1 Completed A Randomized, Comparative Study of Paroxetine in the Treatment of Depression as Used in a Clinical Practice Setting
29060/241 Completed A Double-Blind Study to Compare the Maintenance of Efficacy and Relapse Rates in Patients with Obsessive Compulsive Disorder who Responded to Paroxetine, Clomipramine or Placebo in the Short Term Study 136.
29060/243 Completed An open study to investigate the effects of repeated dosing of paroxetine (20 mg OD for 38 days) on the pharmacokinetics and metabolism of a single dose of desipramine (100 mg) in healthy volunteer subjects
29060/245 Completed A Double-Blind, Multicentre Study in Primary Care Comparing Paroxetine and Clomipramine in Patients with Depression with Associated Anxiety
29060/251 Completed A Double-Blind, Randomized Trial of Paroxetine Versus Placebo In Patients With Depression Accompanied by Anxiety Study Listed on ClinicalStudyDataRequest.com
29060/252 Completed A Multicentre Open Study to Investigate the Safety and Efficacy of Paroxetine in the Treatment of Depressed Patients
29060/253 Completed An Open Pharmacokinetic and Pharmacodynamic Study of Paroxetine (20 – 50mg daily) in the Treatment of Major Depressive Disorder (DSM III)

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.